Claire Mazumdar

Insider Reports History

Location
Bicara Therapeutics Inc., 116 Huntington Avenue, Suite 703, Boston, MA
Signature
/s/ Lara Meisner, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Claire Mazumdar:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Bicara Therapeutics Inc. Chief Executive Officer, Director Common Stock 310K $5.83M $18.83 Oct 16, 2025 Direct
Relay Therapeutics, Inc. Director Stock Option (Right to Buy) 421K Jun 9, 2025 Direct
Bicara Therapeutics Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 277K Oct 16, 2025 Direct

Insider Reports Filed by Claire Mazumdar

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BCAX Bicara Therapeutics Inc. Oct 16, 2025 3 -$362K 4 Oct 20, 2025 Chief Executive Officer, Director
BCAX Bicara Therapeutics Inc. Oct 13, 2025 6 -$373K 4 Oct 15, 2025 Chief Executive Officer, Director
RLAY Relay Therapeutics, Inc. Jun 9, 2025 1 $0 4 Jun 11, 2025 Director
RLAY Relay Therapeutics, Inc. Jun 9, 2025 0 $0 3 Jun 11, 2025 Director
BCAX Bicara Therapeutics Inc. Sep 12, 2024 0 $0 3 Sep 12, 2024 Chief Executive Officer, Director